IMUTEX LIMITED
Company number 10124988 · Monitor this company
Shareholders' funds
-£7,571,049
Balance sheet as at 2024-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2016-04-14
- Dissolved
- 2025-10-21
- Registered office
- London Bioscience Innovation Centre, 2 Royal College Street, London, England, NW1 0NH
- Postcode
- NW1 0NH
- Capital
- 1 GBP
- Accounts category
- Unaudited Abridged
Accounts
- Last made up to
- 2024-12-31
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2025-04-13
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 2 current · 8 resigned
Richard John HUSTON
Director
Kimbell Rush DUNCAN
Director
Group structure
Controlled by PEPTCELL LIMITED — since 2016-04-21
Controlled by HVIVO HOLDINGS LIMITED — since 2016-04-21
From persons-with-significant-control filings on the public register.
Contact details
- Website
- imutex.com
- Phone
- +44 2071536575
Vaccine programmes. A joint venture between PepTcell and hVIVO, Imutex is developing vaccines against influenza and mosquito borne diseases. Find out more!
Previous registered addresses 1
| Address | Changed on |
|---|---|
| 100 FETTER LANE LONDON, EC4A 1BN, UNITED KINGDOM | 2019-03-26 |
The class of 2016
36%
of the 402 companies in this sector incorporated in 2016 are still active today; 59% have since been dissolved.
A fact about the year, not a forecast for this company.